Ligustilide - CAS 4431-01-0
Catalog number:
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
Molecular Weight:
Ligustilide not only has an active dilatory effect on myometrium but also an effective role in reducing the neurogenic and inflammatory pain, thus having the potential to be developed into an effective drug for the treatment of various pain syndromes.
Ordering Information
Catalog Number Size Price Stock Quantity
B0084-474172 100 mg $279 In stock
Bulk Inquiry
Publictions citing BOC Sciences Products
  • >> More
Brife Description:
various pain syndromes
Clear Light Yellow OIl
(3Z)-3-butylidene-4,5-dihydro-2-benzofuran-1-one; 3-Butylidene-4,5-dihydro-1(3H)-isobenzofuranone
Soluble in DMSO
Store at 2-8 °C
Shelf Life:
As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly
Canonical SMILES:
1.Therapeutic Effect of Ligustilide-Stimulated Adipose-Derived Stem Cells in a Mouse Thromboembolic Stroke Model.
Chi K1, Fu RH, Huang YC, Chen SY, Lin SZ, Huang PC, Lin PC, Chang FK, Liu SP. Cell Transplant. 2016;25(5):899-912. doi: 10.3727/096368916X690539. Epub 2016 Jan 18.
Stroke is a result of cerebral ischemia that triggers a cascade of both physiological and biochemical events. No effective treatment is available for stroke; however, stem cells have the potential to rescue tissue from the effects of stroke. Adipose-derived stem cells (ADSCs) are an abundant source of adult stem cells; therefore, ADSC therapy can be considered as a future strategy for regenerative medicine. However, more research is required to improve the effectiveness of transplanted ADSCs as a treatment for stroke in the mouse stroke model. Ligustilide, isolated from the herb Angelica sinensis, exhibits a protective effect on neurons and inhibits inflammation. We also demonstrated that ligustilide treatment increases the expression levels of homing factors such as SDF-1 and CXCR4. In the present study, we evaluated the therapeutic effects of ADSC transplantation and ligustilide treatment in a mouse thromboembolic stroke model by behavioral tests, including beam walking, locomotor activity, and rotarod analysis.
2.Elucidation of Transport Mechanism of Paeoniflorin and the Influence of Ligustilide, Senkyunolide I and Senkyunolide A on Paeoniflorin Transport through Mdck-Mdr1 Cells as Blood-Brain Barrier in Vitro Model.
Hu PY1,2, Liu D3, Zheng Q4, Wu Q5, Tang Y6, Yang M7. Molecules. 2016 Mar 2;21(3). pii: E300. doi: 10.3390/molecules21030300.
The objectives of the present investigation were to: (1) elucidate the transport mechanism of paeoniflorin (PF) across MDCK-MDR1 monolayers; and (2) evaluate the effect of ligustilide (LIG), senkyunolide I (SENI) and senkyunolide A (SENA) on the transport of PF through blood-brain barrier so as to explore the enhancement mechanism. Transport studies of PF were performed in both directions, from apical to basolateral side (A→B) and from basolateral to apical sides (B→A). Drug concentrations were analyzed by LC-MS/MS. PF showed relatively poor absorption in MDCK-MDR1 cells, apparent permeability coefficients (Papp) ranging from 0.587 × 10(-6) to 0.705 × 10(-6) cm/s. In vitro experiments showed that the transport of PF in both directions was concentration dependent and not saturable. The B→A/A→B permeability ER of PF was more than 2 in the MDCK-MDR1 cells, which indicated that the transport mechanism of PF might be passive diffusion as the dominating process with the active transportation mediated mechanism involved.
3.Ligustilide treatment promotes functional recovery in a rat model of spinal cord injury via preventing ROS production.
Xiao W1, Yu A1, Liu D1, Shen J1, Xu Z1. Int J Clin Exp Pathol. 2015 Oct 1;8(10):12005-13. eCollection 2015.
Ligustilide from traditional Chinese medicine extract, angelica sinensis is one of the main active components, and has many pharmacological activities related to the effectiveness. This study sought to determine whether neuro-protection of ligustilide promotes functional recovery in a rat model of spinal cord injury (SCI) via preventing ROS production. Male Sprague-Dawley (SD) rats were induced using operation for model SCI. Furthermore, Basso, Beattie, Bresnahan (BBB) scale and footprint analysis of gait was used to assess the neuro-protection of ligustilide on SCI. The intracellular reactive oxygen species (iROS), prostaglandin E(2) (PGE(2)), interleukin-1β (IL-1β) and tumor necrosis factor (TNF)-α production levels were measured by monoclonal enzyme immunoassay kit. Inducible nitric oxide synthase (iNOS) gene expression, activator protein-1 (AP-1) and c-Jun N-terminal kinase (JNK) protein expressions were detected using Quantitative real-time reverse transcription polymerase chain reaction (Q-PCR) and western blot analyses, respectively.
4.Kelussia odoratissima Mozaff attenuates thromboembolic brain injury, possibly due to its Z-ligustilide content.
Barzegar-Fallah N1, Baery N2, Soleymankhani M3, Malekmohammadi N4, Alimoradi H5, Parsa A6, Barzegar-Fallah A5,7. Brain Inj. 2016 Mar 30:1-7. [Epub ahead of print]
PRIMARY OBJECTIVE: Essential oil (EO) of Kelussia odoratissima Mozaff, whose main composition is Z-ligustilide, has been shown to have strong antioxidant and anti-inflammatory effects and potent neuroprotective properties.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products

CAS 6310-41-4 NSC-41589

(CAS: 6310-41-4)

N-[2-(methylsulfanyl) phenyl]acetamide

CAS 490-46-0 (-)-Epicatechin

(CAS: 490-46-0)

(−)-Epicatechin is a 2R,3R stereoisomer of catechin and is a naturally occurring flavanol. It is a powerful antioxidant and could inhibit cyclooxygenase.

(CAS: 1142090-23-0)

GSK2256294A, an effective inhibitor of human soluble epoxide hydrolase(sEH), was developed by GSK and still under Phase I trial in Chronic obstructive pulmonary...

CAS 80306-38-3 AR-7

(CAS: 80306-38-3)

AR-7, also known as Atypical retinoid 7, was developed as a highly potent and selective enhancer of the chaperone-mediated autophagy (CMA) through antagonizing ...

Glutaminase C-IN-1
(CAS: 311795-38-7)

Glutaminase C-IN-1, with effect to suppresse breast cancer cell growth and invasive activity in vitro, it is an allosteric, cell-permeable and reversible inhibi...

CAS 33620-72-3 Britannilactone

(CAS: 33620-72-3)

A bioassay-guided isolation of the chloroform fraction of the I. britannica using an in vitro melanogenesis inhibition assay led to the isolation of sesquiterpe...

Droxicainide hydrochloride
(CAS: 149572-05-4)

The hydrochloride salt form of Droxicainide, a piperidine derivative, has been found to be an potential antiarrhythmic agent.

CAS 33173-53-4 4-Azido-L-phenylalanine

(CAS: 33173-53-4)

4-Azido-L-phenylalanine is an unnatural derivative of L-phenylalanine. It is a nonpolar, essential amino acid that naturally occurs in the human body and is als...

CAS 50-01-1 Guanidine Hydrochloride

Guanidine Hydrochloride
(CAS: 50-01-1)

Guanidine HCl, the crystalline compound of strong alkalinity formed by the oxidation of guanine, is a normal product of protein metabolism and a protein denatur...

CAS 1184136-10-4 UNC-926

(CAS: 1184136-10-4)

UNC-926 is a methyl-lysine (Kme) reader domain inhibitor which binds to the MBT domain of L3MVTL protein (IC50= 3.9 μM).

(CAS: 1531634-31-7)

AF38469 is a novel, selective, orally bioavailable Sortilin inhibitor and showed no inhibition or stimulation of >50% at 10μM in a standard selectivity panel of...

CAS 140678-14-4 Mangafodipir Trisodium

Mangafodipir Trisodium
(CAS: 140678-14-4)

The trisodium salt form of Mangafodipir that has been found to be a contrast agent through intravenously Mangafodipir Trisodium is a contrast agent delivered in...

ITX-5061 HCl
(CAS: 1252679-52-9)

This active molecular is a scavenger receptor B1 antagonist under the development by iTherX Pharmaceuticals for the treatment of Hepatitis C. ITX-5061 shows a s...

(CAS: 30103-05-0)

DPY-3050 is a useful intermediate for chemical synthesis of a number of biologically active drugs.

CAS 118-60-5 2-Ethylhexyl salicylate

2-Ethylhexyl salicylate
(CAS: 118-60-5)

2-Ethylhexyl salicylate could be commonly used in cosmetics and sunscreens acting as a skin penetration enhancer and could absorb UVB rays at some extent.

CAS 1416992-39-6 GC376

(CAS: 1416992-39-6)

GC376 is a 3CLpro inhibitor which is previously reported to be active against the 3CLpro of multiple coronaviruses, including SARS-CoV, but with highest potency...

CAS 155488-25-8 Sograzepide

(CAS: 155488-25-8)

Sograzepide, a benzodiazepin derivative, has been found to be a gastric receptor as well as CCK2 receptor antagonist that could be useful against chronic atroph...

(CAS: 865608-11-3)

CMPD101 is a selective GRK2/3 inhibitor with IC50 value is 54 nM for GRK3 and 32 nM for GRK2. It shows selectivity for GRK2/3 over GRK1/5. It can also reduce DA...

(CAS: 172430-50-1)

CVT-3248, a piperazineacetamide derivative, could be probably effective in some biological studies.

(CAS: 1547162-46-8)

CC-17369, a hydroxyisoindole derivative, is a metabolites of pomalidomide and has potential activity in anticancer study like multiple myeloma.

Chemical Structure

CAS 4431-01-0 Ligustilide

Quick Inquiry

Verification code

Featured Items